A pilot study in the swine model of lethal cyanide intoxication indicates efficacy of a platinum-methionine complex countermeasure
Authors:
- Vallabh SureshVSVallabh Suresh
- Tara Hendry-HoferTHTara Hendry-Hofer
- Matthew M. BehymerMBMatthew M. Behymer
- Anjali K. NathANAnjali K. Nath
- Shuning ZhengSZShuning Zheng
- Naoaki FujiiNFNaoaki Fujii
- Brian A. LogueBLBrian A. Logue
- Calum A. MacRaeCMCalum A. MacRae
- Randall PetersonRPRandall Peterson
- Gregory T. KnippGKGregory T. Knipp
- Vikhyat S. BebartaVBVikhyat S. Bebarta
Open Access
- 31 May 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Cyanide presents a chemical security threat because of its wide availability, due to industrial uses, and significant toxicity. Platinum-thioether complexes are a recent addition to candidate antidotes, showing efficacy in mouse models of hydrogen cyanide inhalation and reversing toxicity measures in rabbits. This pilot study evaluated the effectiveness of a platinum-methionine complex (Met2Pt), a potent lead candidate, in a lethal swine model, which provides a solid foundation for future research. Potassium cyanide (0.2 mg/kg/min; IV) was infused into anesthetized swine until 6 min post-apnea. Met2Pt (2.9 mg Pt/kg in 3 mL) or 100 mM phosphate buffer vehicle (3 mL) were then administered intravenously (IV) or intramuscularly (IM). Vital signs, metabolites, and pharmacokinetics were monitored for > 90 min. IV Met2Pt was highly efficacious compared to all other treatments, rescuing all swine in the group and reversing cyanide-derangements in lactate concentration (Welch One-Way ANOVA, p < 10- 4), blood oxygenation (p = 0.002), etc. IM Met2Pt did not significantly improve survival due to lower systemic availability (7%). The results of this pilot study indicate that Met2Pt is efficacious via the IV route, while IM availability of Met2Pt is a limiting factor.Keywords
Funding Information
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- National Institutes of Health (U54NS112107)
- U.S. Department of Education (P200A150136)
This publication has 42 references indexed in Scilit:
- Cisplatin Analogs Confer Protection against Cyanide PoisoningCell Chemical Biology, 2017
- Response and legislative changes after the Kiss nightclub tragedy in Santa Maria/RS/Brazil: Learning from a large-scale burn disasterBurns, 2017
- Cyanide Binding Antidotes: Dicobalt Edetate and Hydroxocobalamin2016
- Safety, security and dual-use chemicalsACS Chemical Health & Safety, 2014
- Intravenous Cobinamide Versus Hydroxocobalamin for Acute Treatment of Severe Cyanide Poisoning in a Swine (Sus scrofa) ModelAnnals of Emergency Medicine, 2014
- Hydroxocobalamin and Epinephrine Both Improve Survival in a Swine Model of Cyanide-Induced Cardiac ArrestAnnals of Emergency Medicine, 2012
- Intramuscular Cobinamide Sulfite in a Rabbit Model of Sublethal Cyanide ToxicityAnnals of Emergency Medicine, 2010
- Sodium Thiosulfate or Hydroxocobalamin for the Empiric Treatment of Cyanide Poisoning?Annals of Emergency Medicine, 2007
- Investigations of the impact of effluent from the Ok Tedi copper mine on the fisheries resource in the Fly River, papua new guineaEnvironmental Monitoring and Assessment, 1990
- Cyanide poisoning successfully treated without ‘therapeutic methemoglobin levels’The American Journal of Emergency Medicine, 1989